5% Drop Today In Bristol-Myers Squibb Stock – Mon Jun 4 2018
For the third time in a year and a half, disappointing clinical trials from Bristol-Myers Squibb...
Read MoreFor the third time in a year and a half, disappointing clinical trials from Bristol-Myers Squibb...
Read MoreFor the second time in a year and a half, clinical trials of the Opdivo drug failed to impress and...
Read MoreDisappointing news on Bristol-Myers Squibb’s immunotherapy combo medication has the stock...
Read MoreOne stock that has been in my portfolio for years in Bristol-Myers Squibb Stock. The decline today...
Read MoreIt was just back on September 27 I was writing about the repairs I had entered on my trades in...
Read MoreAnother trade this morning in BMY Stock continues to work my repair of the current trade in...
Read MoreStocks are among the riskiest of assets. They can be incredibly rewarding and can also lead to...
Read MoreRecently I received an email from an investor who was assigned deep in the money naked puts in...
Read MoreBristol-Myers Squibb Stock is once more under selling pressure as various brokerages have...
Read MoreMy last trade in Bristol-Myers Squibb Stock was on July 28 when I sold 10 of the Aug 19 expiry $70...
Read MoreAs members know I have been holding shares and naked puts in Bristol-Myers Squibb Stock since...
Read MoreThe Tomorrow’s trade idea for Feb 1 was Bristol-Myers Squibb Stock. The stock took a tumble...
Read More